Discover Simcyp Biopharmaceutics, our latest addition to the Simcyp suite of technologies. This software empowers drug formulation scientists with advanced model-informed formulation development (MIFD) technology. As a proud member of the Simcyp family, Simcyp Biopharmaceutics provides a robust workbench for formulation development and optimization, maintaining the Simcyp gold standard for unparalleled formulation success.
Join us for an exclusive webinar, “Advancing Formulation Excellence with Simcyp Biopharmaceutics,” where our team of experts and special guest, Dr. Jennifer Dressman will unveil the innovative features and applications of this groundbreaking tool.
What You Will Learn:
- Elevate your formulation strategies for informed decision-making
- Leverage Simcyp Biopharmaceutics to accelerate your formulations
- Navigate the complexities of novel and generic drugs
- Enhance biowaiver success rates
Don’t miss this opportunity to gain valuable insights and experience Simcyp Biopharmaceutics in action. Secure your spot today by registering.
Special Guest:
Dr. Jennifer Dressman, who retired as Professor of Pharmaceutical Technology at the Goethe University in 2021, now leads a formulation group at the Fraunhofer Institute of Translation Medicine and Pharmacology in Frankfurt am Main, Germany.
Prof. Dressman’s research interests focus principally on predicting the in vivo performance of drugs and dosage forms after oral administration. She is best known for pioneering the use of Biorelevant dissolution testing and her contributions to combining dissolution testing with physiologically based pharmacokinetic modelling in order to achieve quantitative predictions of oral drug absorption.
In recognition of her research excellence, she has been made a Fellow of the AAPS, the CRS, AJPST and the FIP. In 2008 she was awarded the Distinguished Scientist Award of the FIP and in 2017 was named the International Woman Pharmaceutical Scientist of the Year by the APSTJ. In 2022 a special issue of the Journal of Pharmaceutical Sciences was dedicated to her contributions to the Pharmaceutical Sciences.
